Given that RNU6-2 is not a miRNA itself and could be released and expressed at different levels between normal and cancer patients, based on the results, we could also speculate that the miR-940/RNU6-2 combination in cancer serum is higher than in normal serum. Here, RNU6-1 is linked to cancer.